EXELA HOLDINGS, INC.

 EXELA HOLDINGS, INC. contact information is shown below
Owner:EXELA HOLDINGS, INC.
Owner Address:1245 Blowing Rock Blvd. Lenoir NC 28645
Owner Web Site
Owner Phone
Owner Toll Free
Owner Fax

 

Brands Owned byEXELA HOLDINGS, INC.

Brand:

CALSTRYN

Description:

Medical diagnostic test media in the form of chemical agents for diagnosing thyroid cancer; medical diagnostic test chemical agents administered to patients for use in the field of oncology;

Category: MEDICAL DIAGNOSTIC TEST MEDIA
Brand:

CYSALO

Description:

Pharmaceutical products, namely, pharmaceutical preparations for treatment or prevention of metabolic conditions, metabolic disorders and metabolic deficiencies;

Category: PHARMACEUTICAL PRODUCTS
Brand:

ELCIS

Description:

Pharmaceutical products and pharmaceutical preparations for treatment or prevention of metabolic conditions, metabolic disorders and metabolic deficiencies;

Category: PHARMACEUTICAL PRODUCTS PHARMACEUTICAL PREPARATIONS
Brand:

ELCIS

Description:

Pharmaceutical products and pharmaceutical preparations for treatment or prevention of amino acid deficiencies;

Category: PHARMACEUTICAL PRODUCTS PHARMACEUTICAL PREPARATIONS
Brand:

ELCYS

Description:

Pharmaceutical products and pharmaceutical preparations for treatment or prevention of amino acid deficiencies;

Category: PHARMACEUTICAL PRODUCTS PHARMACEUTICAL PREPARATIONS
Brand:

EXELA

Description:

Product development in the field of developing pharmaceutical products in specialized dosage forms, namely, controlled drug-releasing formulations, sterile products, topical products, and attendant analytical services;

Category: PRODUCT DEVELOPMENT FIELD
Brand:

EXELA

Description:

In the statement, line 9 after disorders, excluding pharmaceutical preparations and substances that are directly targeted for the treatment of cancer is inserted.;Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, * excluding pharmaceutical preparations and substances that are directly targeted for the treatment of cancer *;

Category: STATEMENT
Brand:

EXELA

Description:

The mark consists of a container with a stirrer together with the words EXELA in an oval shape in the middle of the container.;In the statement, line 9 after disorders, excluding pharmaceutical preparations and substances that are directly targeted for the treatment of cancer is inserted.;Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, * excluding pharmaceutical preparations and substances that are directly targeted for the treatment of cancer *;Color is not claimed as a feature of the mark.;Product development consulting in the field of developing pharmaceutical products in specialized dosage forms, namely, controlled drug-releasing formulations, sterile products, topical products, and attendant analytical services;

Category: